Speaker :

Dr. Nagender Sharma, Medical Oncologist, Delhi

Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine  for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the   HER2CLIMB Trial                                                                                                                           

Author: Nancy U Lin

Citation: J Clin Oncol. 2020 Aug 10;38(23):2610-2619

Tucatinib vs placebo added to trastuzumab and capecitabine in previously treated  HER2+ metastatic breast cancer with and without brain metastases (HER2CLIMB)

Author: Giuseppe Curigliano        

Citation: Annals of Oncology (2020) 31 (suppl_2): S62-S82 

Tucatinib, Trastuzumab, and Capecitabine for HER2-Positive Metastatic Breast Cancer                                                                                                                              

Author: Rashmi K. Murthy

Citation: N Engl J Med 2020; 382:597-609